Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-128-3 | CAS number: 556-52-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Effect on fertility: via oral route
- Dose descriptor:
- NOAEL
- 3.3 mg/kg bw/day
Additional information
In a study conducted by Brown-Woodman et al(1979), the test substance was evaluated for its ability to induce reproductive toxicity when administered to male Wistar rats via intraperitoneal injection over a period of 14 days. The test substance was administered at a concentration of 3.3 mg/kg b.w. Following 7 days of treatment, the males were cohabited with 2 females and the presence of spermatozoa in vaginal smears was taken as evidence of mating. Pregnancy and litter sizes in females were determined 20 days after mating. Under the conditions of this study, no effects were observed on fertility. There was a reduction in the number of spermatozoa counted in vasa deferentia, mean litter size, mean embryo weight and sperm motility. No effect on body, testes and spleen weight, epididymal and thymus hypertrophy. Based on these results, the NOAEL was determined to be 3.3 mg/kg bw/day. Under the conditions of this study, the test substance does not require classification according to Regulation EC No. 1272/2008 or Directive 67/548/EEC.
No data on developmental and reproductive effects in humans were available to the WHO Working Group (IARC Monograph Vol. 77) but the group evaluated available animal study results and concluded no effects on fertility or development were observed in mice given intraperitoneal injections of glycidol 24 h before mating or orally during organogenesis. In contrast, when a single dose of glycidol was administered to female mice within 25 h after mating, the numbers of fetal deaths and anomalies were increased. Intraamniotic injection of glycidol on day 13 of gestation in rats increased the frequency of resorptions and, at high doses, limb malformations.
Short description of key information:
A key study is available. The study was conducted in male Wistar rats administered the test substance via intraperitoneal injection.
Effects on developmental toxicity
Description of key information
One key study is available. The study was conducted in female rats exposed to the test substance via inhalation exposure.
Effect on developmental toxicity: via inhalation route
- Dose descriptor:
- NOAEC
- 14.5 mg/m³
Additional information
In a study conducted by Koeter and Appelman (1980) the test substance, Glycidol, was examined for its ability to cause reproductive toxicity when administered to female rats. The test animals were exposed via inhalation, at concentrations of 0, 50, 150 and 300ppm, although due to overt toxicity observed at the highest dose level, this was reduced to 250ppm after 11 days exposure. The female rats were mated and pregnancy was confirmed by the presence of sperm in a vaginal smear (day 0 of pregnancy). The females were exposed to the test substance for 6 hours, from days 6 to 16 of pregnancy.
Clinical observations and body weight were recorded from day 0 to day 21, at which point the animals were sacrificed. The uterus and ovaries were removed and examined and the number of corpura lutea, implantation sites and the number of early and late resorptions were recorded. Half the foetueses from each litter were examined for soft tissue abnormalities and half for skeletal malformations. Under the conditions of this study, the NOAEC for maternal rats was determined to be 53ppm while the NOAEC was determined to be 145ppm for embryo/foetotoxicity. Under the conditions of this study, the test substance does not require classification according to Regulation EC No. 1272/2008 or Directive 67/548/EEC.
Justification for classification or non-classification
Effects on fertility:
Under the conditions of the key study, the test substance, Glycidol, does not require classification acording to Regulation EC No. 1272/2008 or Directive 67/548/EEC, although some effects were evident affecting
a reduction in the number of spermatozoa counted in vasa deferentia, reduced mean litter size, lower mean embryo weight and reduced sperm motility. Evidence from the supporting studies was equivocal, with no clearly identified effects on fertility or reproductive performance.
However, glycidol is classified in Annex VI of Regulation 1272/2008 as a Repr. Cat 1B and despite the lack of confirmatory evidence in the studies presented in the dossier, the harmonised classification was adopted. Glycidol is therefore classified as Repr. 1B, H360F according to GHS and Repr. Cat 2, R60 may impair fertility in accordance with Directive 67/548/EEC (as subsequently amended).
.Developmental Toxicity/Teratogenicity:
Under the conditions of this study, the test substance does not require classification according to Regulation EC No. 1272/2008 or Directive 67/548/EEC.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.